Cargando…
Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression
Hormone-receptor positive (HR+) breast cancer (BC) (including the luminal A and the luminal B subtypes) is the most common type of tumor in women diagnosed with early-stage BC (EBC). It represents a highly heterogeneous subgroup that is characterized by different risks of relapse. The aim of this re...
Autores principales: | Pellegrino, Benedetta, Hlavata, Zuzana, Migali, Cristina, De Silva, Pushpamali, Aiello, Marco, Willard-Gallo, Karen, Musolino, Antonino, Solinas, Cinzia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249273/ https://www.ncbi.nlm.nih.gov/pubmed/33974235 http://dx.doi.org/10.1007/s40291-021-00525-7 |
Ejemplares similares
-
LAG3: The Biological Processes That Motivate Targeting This Immune Checkpoint Molecule in Human Cancer
por: Solinas, Cinzia, et al.
Publicado: (2019) -
Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review
por: Pellegrino, B., et al.
Publicado: (2020) -
Programmed Cell Death-Ligand 2: A Neglected But Important Target in the Immune Response to Cancer?
por: Solinas, Cinzia, et al.
Publicado: (2020) -
The Innate Immune Microenvironment in Metastatic Breast Cancer
por: Tommasi, Chiara, et al.
Publicado: (2022) -
Immunotherapy Associated Pulmonary Toxicity: Biology Behind Clinical and Radiological Features
por: Porcu, Michele, et al.
Publicado: (2019)